Stimuli-free programmable drug release for combination chemo-therapy.
暂无分享,去创建一个
Li Fan | Chaojun Song | Quan Li | Chao-jun Song | Boquan Jin | Quan Li | Boquan Jin | Silu Zhang | L. Fan | Silu Zhang
[1] K. B. Sutradhar,et al. Nanotechnology in Cancer Drug Delivery and Selective Targeting , 2014 .
[2] G. Bonadonna,et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. , 1976, The New England journal of medicine.
[3] B. Lambrecht,et al. Photodynamic virus inactivation of blood components. , 1995, Immunological investigations.
[4] Andrew J Matisoff,et al. Methylene blue treatment for methemoglobinemia and subsequent dramatic bispectral index reduction. , 2006, Anesthesiology.
[5] Samir Mitragotri,et al. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.
[6] J. Lehár,et al. Synergistic drug combinations improve therapeutic selectivity , 2009, Nature Biotechnology.
[7] Guangjun Nie,et al. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy. , 2012, Current drug metabolism.
[8] Li Yang,et al. Driving forces for drug loading in drug carriers , 2015, Journal of microencapsulation.
[9] B. Robinson,et al. Low-concentration methylene blue maintains energy production and strongly improves survival of Leigh syndrome French Canadian skin fibroblasts. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[10] J. Shumaker,et al. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization , 1994, Transfusion.
[11] G. Lin,et al. Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles. , 2013, Journal of the American Chemical Society.
[12] Zhen Gu,et al. Programmable nanomedicine: synergistic and sequential drug delivery systems. , 2015, Nanoscale.
[13] Eun-Kyung Lim,et al. Delivery of Cancer Therapeutics Using Nanotechnology , 2013, Pharmaceutics.
[14] Kinam Park. Nanotechnology: What it can do for drug delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[15] R. Mumper,et al. Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review. , 2013, Nano today.
[16] Erik C. Dreaden,et al. A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways , 2014, Science Signaling.
[17] C. M. Allen,et al. Photodynamic therapeutics: basic principles and clinical applications. , 1999, Drug discovery today.
[18] Liangfang Zhang,et al. Nanoparticle-assisted combination therapies for effective cancer treatment. , 2010, Therapeutic delivery.
[19] P. Grodzinski,et al. Highlights of recent developments and trends in cancer nanotechnology research--view from NCI Alliance for Nanotechnology in Cancer. , 2014, Biotechnology advances.
[20] R. Tekade,et al. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[21] Yong-Eun Koo Lee,et al. Methylene blue-conjugated hydrogel nanoparticles and tumor-cell targeted photodynamic therapy. , 2011, Macromolecular bioscience.
[22] He Zhang,et al. Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes. , 2009, International journal of pharmaceutics.
[23] V. Torchilin. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery , 2014, Nature Reviews Drug Discovery.